About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Case Report 
Massive hyper-progression during anti-PD1 immunotherapy in a young patient with metastatic mucinous adenocarcinoma of the right colon: a case report and literature review
Chiara Guarini, Annalisa Todisco, Marco Tucci, Camillo Porta, Francesco Mannavola
Precision Cancer Medicine  
2021;
4:
30  
Review Article 
Women treating lung cancer: a narrative review
Maria Teresa R. Tsukazan, Ana Gelatti, Paula A. Ugalde
Precision Cancer Medicine  
2021;
4:
29  
Review Article 
Next-generation sequencing using liquid biopsy in the care of patients with ALK-rearranged non-small cell lung cancer: a focus on lorlatinib
Juan B. Blaquier, Andrés F. Cardona, Alessandro Russo, Christian Rolfo, Gonzalo Recondo
Precision Cancer Medicine  
2021;
4:
28  
Review Article 
Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches—a narrative review
Alicia A. Zolondick, Giovanni Gaudino, Jiaming Xue, Harvey I. Pass, Michele Carbone, Haining Yang
Precision Cancer Medicine  
2021;
4:
27  
Review Article 
Sex-based heterogeneity in non-small cell lung cancer (NSCLC) and response to immune checkpoint inhibitors (ICIs): a narrative review
Stefano Frega, Alessandra Ferro, Laura Bonanno, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Precision Cancer Medicine  
2021;
4:
26  
Review Article 
ROS1 non-small cell lung cancer patients treatment approach
Laura Moliner, Edurne Arriola
Precision Cancer Medicine  
2021;
4:
25  
Review Article 
A narrative review of biomarkers in advanced triple negative breast cancer
Rania Chehade, Arif A. Awan, Ricardo Fernandes
Precision Cancer Medicine  
2021;
4:
24  
Review Article 
A narrative review of predictive and prognostic biomarkers in skin tumors
Anna M. Stagner, Rosalynn M. Nazarian
Precision Cancer Medicine  
2021;
4:
22  
Editorial Commentary 
PARP inhibitors beyond BRCA-mutated cancers: precision medicine at the crossroads
Bartłomiej Tomasik, Michał Bieńkowski, Jacek Jassem
Precision Cancer Medicine  
2021;
4:
19  
Editorial Commentary 
Lung cancer screening: think pink!
Monica Casiraghi, Lorenzo Spaggiari
Precision Cancer Medicine  
2021;
4:
18  
Case Report 
Effectiveness of pemetrexed-based chemotherapy and radiation therapy in RET-rearranged lung adenocarcinoma: a mono-institutional case series
Fabrizio Citarella, Marco Russano, Alessandro Galletti, Giuseppina-Rita Di Fazio, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2021;
4:
17  
Review Article 
ROS-1 NSCLC therapy resistance mechanism
Miguel García-Pardo, Antonio Calles
Precision Cancer Medicine  
2021;
4:
16  
Review Article 
Monitoring therapeutic response and resistance with liquid biopsy
Virginia Calvo, Atocha Romero, Mariano Provencio
Precision Cancer Medicine  
2021;
4:
15  
Review Article 
Non-small cell lung cancer molecular characterization of advanced disease with focus on sex differences: a narrative review
Rossella Bruno, Greta Alì, Anello Marcello Poma, Gabriella Fontanini
Precision Cancer Medicine  
2021;
4:
14  
Review Article 
A narrative review of chemotherapy in advanced triple negative breast cancer
Maria L. Romero Lagunes, Rossanna C. Pezo
Precision Cancer Medicine  
2021;
4:
13  
Review Article 
Triple negative breast cancer: emerging light on the horizon—a narrative review
Umangjot K. Bharaj, Ana E. Lohmann, Phillip S. Blanchette
Precision Cancer Medicine  
2021;
4:
12  
Original Article 
The use of stereotactic body radiotherapy in pulmonary carcinoid tumors: a case series
Katharine Thomas, Chris Smith, Andrew Marsala, John Philip Boudreaux, Ramcharan Thiagarajan, Robert A. Ramirez
Precision Cancer Medicine  
2021;
4:
11  

Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa